Skip to main content
. 2017 Mar 31;87(4):254–263. doi: 10.1159/000467393

Table 4.

Backward regression analysis of BA SDS

Coefficient 95% CI R2 p value
Total cohort (n = 88)
 Constant 2.17 1.39/2.96 <0.001
 Male sex 0.62 0.18/1.06 0.006
 DHEAS SDS 0.27 0.09/0.44 <0.001
 Age −0.13 −0.20/–0.06 0.036
 Model 0.27 <0.001

Female (n = 52)
 Constant 2.68 1.25/4.11 0.001
 DHEAS SDS 0.34 0.01/0.66 0.042
 SHBG SDS 0.29 −0.04/0.62 0.086
 Age −0.14 −0.26/–0.02 0.024
 Model 0.21 0.030

Male (n = 46)
 Constant 2.81 1.80/3.81 <0.001
 DHEAS SDS 0.31 0.09/0.52 0.006
 Age −0.14 −0.22/–0.05 0.002
 Model 0.30 <0.001

Prepubertal (n = 36)
 Constant 2.26 1.17/4.02 0.001
 Male sex 0.98 0.30/1.67 0.006
 SHBG SDS −0.41 −0.76/–0.09 0.013
 Age −0.27 −0.46/–0.07 0.009
 Model 0.31 0.006

Pubertal (n = 37)
 Constant 0.70 0.32/1.08 0.001
 DHEAS SDS 0.43 0.01/0.85 0.046
 Model 0.11 0.046

Variables included in all models: age, fasting insulin, HOMA-IR, AUC insulin, DHEAS SDS, SHBG SDS. In the total cohort and pubertal subgroups, sex was added as an independent variable. In the pubertal subgroup only, oestradiol SDS and testosterone SDS were added as independent variables. BA, bone age; HOMA-IR, homeostatic model assessment of insulin resistance; SHBG, sex hormone-binding globulin; DHEAS, dehydroepiandrosterone sulphate; SDS, standard deviation score.